• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Imaging and Intervention

Amyloid may cause distant cerebral hypometabolism in Alzheimer’s

byDavid WangandAaron Maxwell, MD
February 19, 2015
in Imaging and Intervention, Neurology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. In a longitudinal study of 15 patients with Alzheimer’s disease (AD), regions of isolated cerebral hypometabolism detected by FDG-PET correlated with increase in amyloid deposition in anatomically separate but functionally connected brain regions.

Evidence Rating Level: 3 (Average)  

Study Rundown: The current understanding of Alzheimer’s disease (AD) pathophysiology involves deposition of amyloid plaques resulting in localized cerebral inflammation and toxicity. Previous work using position emission tomography (PET) of the brain in patients with AD using radioligands for metabolism (fludeoxyglucose, or 18F-FDG) and amyloid plaques (Pittsburg Compound B, or 11C-PiB) have shown strong correlation between the area of hypometabolism and high amyloid deposition. However, FDG-PET has also demonstrated that AD brains contain areas in which brain hypometabolism occur without high-amyloid burden. The purpose of this trial was to explore the hypothesis that these hypometabolism-only (HO) areas are related to amyloid toxicity of anatomically remote, but functionally related areas of the brain. The authors prospectively evaluated 15 patients with AD with baseline and follow-up PET examinations using 18F-FDG and 11C-PiB over a span of two years and correlated their findings with internal functional connectivity maps as determined by resting-state functional MRI (rs-fMRI). At the conclusion of the trial, the authors found a significant positive correlation between the longitudinal changes in metabolism of the HO-areas with remote functionally interconnected brain regions. Furthermore, the authors reported a significant correlation between the loss of metabolism in the HO-regions and clinical cognitive decline. The results of this study support the hypothesis that a decrease in brain metabolism can decrease as a result of amyloid toxicity of remote, but functionally connected regions. However, the study is limited by the small sample size; larger studies are required to accurately describe this relationship.

Click to read the study in Journal of Nuclear Medicine

Relevant Reading: Advances in dementia imaging

In-Depth [prospective cohort]: This study prospectively followed 15 patients diagnosed with mild AD and 15 health controls with baseline 11C-PiB and 18F-FDG-PET and follow-up scans two years post study enrollment. In order to identify HO-regions, threshold subtraction of 18F-FDG-PET was performed from AD patients and healthy controls. Functionally connected brain networks were identified via intrinsic functional connectivity analysis from resting state fMRI collected from healthy controls. Statistical analysis was performed by region-of-interest-based and voxel-based correlations with the intrinsic connectivity-based analysis. At the conclusion of the study, there was a significant positive correlation between the decrease in 18F-FDG-PET signal in the HO-region and 11C-PiB signal changes in the remote ICN (r=0.537, P=0.039) as well as in areas typically affected by AD, namely the posterior cingulate cortex (r=0.677, P=0.006) and precuneus (R=0.691, p=0.004). This correlation was not observed between the HO-region and brain regions outside of the ICN (r=0.470, P=0.077). The decline of metabolism in the HO-area was also significantly correlated with clinical decline as measured by the mini-mental status exam (r=0.695, P=0.004)

Image: PD

RELATED REPORTS

#VisualAbstract: Anti-tau antibody Semorinemab not shown to slow clinical progression of Alzheimer’s disease

Anti-tau antibody Semorinemab not shown to slow clinical progression of Alzheimer’s disease

Rare APOE missense variants V236E and R251G associated with substantial reduction in risk of Alzheimer disease

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Alzheimer’s diseaseamyloid
Previous Post

Combined MRI and NIH stroke scores may predict stroke prognosis

Next Post

Long-acting opioid use linked to higher risk of overdose

RelatedReports

#VisualAbstract: Varenicline improves successful smoking cessation amongst African American daily smokers: KIS-IV Trial
StudyGraphics

#VisualAbstract: Anti-tau antibody Semorinemab not shown to slow clinical progression of Alzheimer’s disease

June 29, 2022
Genetic risk assessment for Alzheimer’s disease does not increase anxiety, depression or stress
Chronic Disease

Anti-tau antibody Semorinemab not shown to slow clinical progression of Alzheimer’s disease

June 17, 2022
Amyloid pathology may be detected decades prior to Alzheimer’s diagnosis
Chronic Disease

Rare APOE missense variants V236E and R251G associated with substantial reduction in risk of Alzheimer disease

June 2, 2022
Genetic risk assessment for Alzheimer’s disease does not increase anxiety, depression or stress
Chronic Disease

Alzheimer disease in individuals with Down syndrome has similar variability in age of onset and mortality rate as autosomal dominant forms

May 26, 2022
Next Post
Multiple opioid prescriptions associated with higher hospital admissions

Long-acting opioid use linked to higher risk of overdose

Classics Series, Landmark Trials in Medicine

Diffusion-weighted MRI highly sensitive, specific vs. CT in acute ischemic stroke [Classics Series]

Conjugated equine estrogens may elevate risk of venous thrombosis

Postmenopausal hormone replacement therapy use associated with increased ovarian cancer risk

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • APOEε4 genotype may increase risk of chronic traumatic encephalopathy following repetitive head impact
  • The RAPTURE trial: Radiofrequency ablation effective and safe in lung cancer [Classics Series]
  • Relugolix combination therapy is efficacious for endometriosis-associated pain
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.